Literature DB >> 24910304

Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis.

Guillemette Thomas1, Julien Mancini, Noémie Jourde-Chiche, Gabrielle Sarlon, Zahir Amoura, Jean-Robert Harlé, Eric Jougla, Laurent Chiche.   

Abstract

OBJECTIVE: To assess the mortality profile of systemic lupus erythematosus (SLE) patients in France using multiple-cause-of-death analysis.
METHODS: Data were collected between 2000 and 2009 in the French Epidemiological Center for the Medical Causes of Death database, and death certificates issued upon the death of an adult for whom SLE was an underlying cause of death (UCD) or a non-underlying cause of death (NUCD) were evaluated using multiple-cause-of-death analysis. Sex, age, sex ratio, standardized mortality rates, as well as frequency of the various causes of death were assessed, at both a national and a regional level. For the main causes of death, the observed number of deaths in relation to the expected number of deaths (O:E ratio) (standardized for age and sex) was calculated.
RESULTS: During the study period, 1,593 deaths related to SLE were identified. The mean ± SD age at death was 63.5 ± 18.4 years and the sex ratio (female:male) was 3.5. The mean standardized mortality rate was 3.2 per 1 million people (range 2.7-4.1). When SLE was the UCD (n = 637), the main NUCDs were cardiovascular diseases (49.5%), infectious diseases (24.5%), and renal failure (23.2%). When SLE was an NUCD (n = 956), the most common UCDs were cardiovascular diseases (35.7%), neoplasms (13.9%), and infectious diseases (10.3%). The overall O:E ratio was >1 for infectious and cardiovascular diseases and renal failure (especially among people <40 years of age for the latter 2 causes), but was <1 for neoplasms.
CONCLUSION: Cardiovascular disease is the leading cause of death associated with SLE in France.
Copyright © 2014 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2014        PMID: 24910304     DOI: 10.1002/art.38731

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  49 in total

Review 1.  Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.

Authors:  M Wigren; J Nilsson; M J Kaplan
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

Review 2.  A review on SLE and malignancy.

Authors:  May Y Choi; Kelsey Flood; Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E Clarke
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-11-10       Impact factor: 4.098

3.  Do Death Certificates Underestimate the Burden of Rare Diseases? The Example of Systemic Lupus Erythematosus Mortality, Sweden, 2001-2013.

Authors:  Titilola Falasinnu; Marios Rossides; Yashaar Chaichian; Julia F Simard
Journal:  Public Health Rep       Date:  2018-06-21       Impact factor: 2.792

Review 4.  Mortality in Systemic Lupus Erythematosus: an Updated Review.

Authors:  César E Fors Nieves; Peter M Izmirly
Journal:  Curr Rheumatol Rep       Date:  2016-04       Impact factor: 4.592

Review 5.  Malignancies in systemic lupus erythematosus: a 2015 update.

Authors:  Gillian C Goobie; Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E Clarke
Journal:  Curr Opin Rheumatol       Date:  2015-09       Impact factor: 5.006

6.  Brief Report: Lupus-An Unrecognized Leading Cause of Death in Young Females: A Population-Based Study Using Nationwide Death Certificates, 2000-2015.

Authors:  Eric Y Yen; Ram R Singh
Journal:  Arthritis Rheumatol       Date:  2018-06-27       Impact factor: 10.995

7.  Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.

Authors:  Philip M Carlucci; Monica M Purmalek; Amit K Dey; Yenealem Temesgen-Oyelakin; Simantini Sakhardande; Aditya A Joshi; Joseph B Lerman; Alice Fike; Michael Davis; Jonathan H Chung; Martin P Playford; Mohammad Naqi; Pragnesh Mistry; Gustavo Gutierrez-Cruz; Stefania Dell'Orso; Faiza Naz; Taufiq Salahuddin; Balaji Natarajan; Zerai Manna; Wanxia L Tsai; Sarthak Gupta; Peter Grayson; Heather Teague; Marcus Y Chen; Hong-Wei Sun; Sarfaraz Hasni; Nehal N Mehta; Mariana J Kaplan
Journal:  JCI Insight       Date:  2018-04-19

8.  Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil.

Authors:  Jordana Vaz Hendler; Lucian de Souza; Daniele Corrêa de Freitas Zernow; Juliano Guimarães; Thiago Bertotto; Carla Forgiarini Saldanha; João Carlos Tavares Brenol; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2017-06-26       Impact factor: 2.980

9.  E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis.

Authors:  Zhenlu Chong; Chunjing Bao; Jia He; Tianxiao Chen; Lijia Zhong; Gaopeng Li; Huanle Li; Lutong Fang; Yinjing Song; Guoxiang Fu; Xuyan Yang; Lihua Lai; Yang Liu; Qingqing Wang
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

10.  Impact of Sex on Systemic Lupus Erythematosus-Related Causes of Premature Mortality in the United States.

Authors:  Titilola Falasinnu; Yashaar Chaichian; Julia F Simard
Journal:  J Womens Health (Larchmt)       Date:  2017-09-11       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.